A Leader In EndoVascular Education Award — The LIVE Award recognizes those vascular specialists who have dedicated their professional careers to educating students, postgraduate trainees, and peers in all aspects of vascular medicine and intervention. Please join us in the Global Theater on Tuesday, November 6 at 9:05 AM to congratulate this year's recipient of the LIVE Award.
Dr. Dierk Scheinert, MD, serves as head of the Department of Angiology at the University Hospital, Leipzig Germany. Dr. Scheinert has developed an international referral center for multidisciplinary and multimodality management of arterial disease. He serves as a member of the medical advisory board at AngioScore, Inc. He serves as a member of the scientific advisory board of AngioSlide, Ltd. and Gardia Medical Ltd. Dr. Scheinert has published extensively and is a sought-after lecturer on his primary research focus: the minimally invasive treatment of arteriosclerosis and other cardiovascular problems. He attended Medicine School-Charité. Dr. Scheinert studied at the Department of Medicine (Cardiology/Angiology) Virchow Klinkum, Humbold, University Berlin and the Department of Medicine II (Cardiology/ Angiology) Friedrich-Alexander-University Erlangen-Nuremberg.
THOMAS ZELLER, MD
MARK BATES, MD
TIMOTHY SULLIVAN, MD
J. MICHAEL BACHARACH, MD
JOHN LAIRD JR., MD
MICHAEL DAKE, MD
MARK WHOLEY, MD
MICHAEL R. JAFF, DO
GARY ANSEL, MD
EDWARD DIETHRICH, MD
L. NELSON HOPKINS III, MD
BARRY KATZEN, MD
KENNETH ROSENFIELD, MD
A Teacher, Leader, And Scholar Award — The ATLAS Award celebrates the career and impact of physicians who have distinguished themselves as scholars and leaders in their respective vascular fields. They have committed their careers to advancing the care of patients with vascular disorders, and they have taught countless numbers of physicians techniques to expand care across the United States and the world. Please join us in the Global Theater on Tuesday, November 6 at 9:10 AM to congratulate this year's recipient of the ATLAS award.
Dr. Veith graduated from Cornell University Medical School with Honors before completing an internship at Columbia - P&S and his surgical residency training at Peter Bent Brigham Hospital and Harvard Medical School. Thereafter he achieved success with his pioneering work in experimental and clinical lung transplantation.
In the 70s and 80s, his attention turned toward Vascular Surgery with an emphasis on lower extremity revascularization procedures. He and his colleagues were the first to advocate an aggressive approach to saving limbs threatened by arteriosclerosis and gangrene when most patients with this problem were being treated by a major amputation. He and his group were recognized as world leaders in this field.
In the 1990s, Dr. Veith, an advocate of endovascular treatments, became involved with endovascular grafts, using them to treat a variety of vascular lesions. Many of the procedures he and his associates performed were “firsts,” including the first endovascular graft repair of an abdominal aortic aneurysm or EVAR in the US and an EVAR for a ruptured abdominal aneurysm. He was elected President of the Society for Vascular Surgery (SVS) and was a major force promoting the endovascular treatment.
Dr. Veith held positions as Chief of Vascular Surgery and Chairman of Surgery at Montefiore Medical Center-Albert Einstein College of Medicine for many years. He was also The William J. Von Liebig Chair in Vascular Surgery at these institutions. In 2006, Dr. Veith was appointed to his present positions, at New York University and the Cleveland Clinic. Over the years, he has received numerous awards and honors as a leader, outstanding teacher and innovator in Vascular Surgery. He chairs a large Vascular meeting, the VEITHsymposium, held annually in New York City.
|2017||NICK HOPKINS, MD|
|2016||THOM ROOKE, MD|
|2015||GARY S. ROUBIN, MD|
|2014||BARRY T. KATZEN, MD|
|2013||JERRY GOLDSTONE, MD|
|2012||JOHN SPITTELL, MD|
|2011||GIANCARLO BIAMINO, MD, PHD|
|2010||ERNEST RING, MD|
|2009||JESS YOUNG, MD|
|2008||NORMAN HERTZER, MD|
VIVA and LINC have collaborated to develop the Vascular Career Advancement Award to recognize young physicians who show promise as potential leaders in the vascular field. Recipients are selected for their dedication to a philosophy of multidisciplinary vascular care and improving the care and outcomes of patients with vascular disease. Please join us in the Global Theater on Wednesday, November 7 at 8:05 AM to congratulate this year's recipients of the VCA Award.
Dr. Osamu Iida is an established and highly skilled physician with more than 17 years of experience. He has a great deal of experience in endovascular treatment, specifically thoracic, abdominal, and lower limbs vessels with more than 1,000 cases per year. He is the associate director of the Cardiovascular Center at Kansai Rosai Hospital and serves as the chief of coronary, endovascular, and structure treatments. He was selected as one of the Best Doctors in Japan 2016-2017 by Teradoc, Inc. As a researcher, Dr. Iida has published 35 original papers as the primary author and co-authored more than 150 papers. His main research interests are clinical research of SFA treatment using IVUS, research about angiosomes (CLI single-site study), and various studies that impact many treatment strategies (CLI multicenter study).
Dr. Sabine Steiner earned her medical degree from the Medical University Vienna, Austria, in 2000, where she also completed her training in internal medicine and angiology. For her research activity on restenosis and vascular regeneration she received her venia docendi (habilitation) from the Medical University Vienna in 2006 and held an appointment as associate professor at the Division of Angiology since 2012. From 2009-2011 she pursued a postdoctoral fellowship at the Ottawa Heart Institute, Canada, funded by an Erwin Schrödinger fellowship of the Austrian Science Fund. During her stay she also successfully completed a Master of Science in Epidemiology. In 2013 she joined the interventional team of Prof. Scheinert at the Department of Angiology, Park-Krankenhaus Leipzig and later at the Medical University Leipzig, Germany, where she deepened her endovascular training in the full range of peripheral vascular interventions. In 2014 she was appointed senior physician and currently works part-time in Leipzig and Vienna after the birth of her baby boy.
Dr. Steiner has contributed to around 100 publications, 25 of them as first or last author. She has a broad scientific background comprising various aspects of vascular medicine (endovascular techniques, epidemiology, angiogenesis, anticoagulation) with a focus on peripheral interventions and clinical trials. She has given several international and national invited talks. She is a regular reviewer for various journals in the field of cardiovascular medicine.
|2017 - 2018||EHRIN ARMSTRONG, MD & DANIELA BRANZAN, MD|
|2016 - 2017||SAHER SABRI, MD & ANTONIO MICARI, MD|
|2015 - 2016||RAGHU KOLLURI, MD & THEODOSIOS BISDAS, MD, PHD|
|2014 - 2015||FELIX MAHFOUD, MD & GUSTAVO ODERICH, MD|
|2013 - 2014||MEHDI SHISHEBOR, DO & MARTIN WERNER, MD|
New this year! The VIVA board has created the VEINS Award—Venous Educator, Innovator, and National Statesman to honor individuals who have made significant contributions to improving the care of patients with venous disease. Please join us in Mouton 1 & 2 during The VEINS session Monday, November 5 at 7:45 AM to congratulate the inaugural recipient of the VEINS Award.
Dr. Goldhaber is a professor of medicine at Harvard Medical School, the interim chief of the Division of Cardiovascular Medicine, section head of Vascular Medicine, and director of the Thrombosis Research Group at Brigham and Women’s Hospital. He serves as the principal investigator of a broad range of
randomized clinical trials and observational studies related to the prevention, treatment, and epidemiology of venous thromboembolism; stroke prevention in atrial fibrillation; and novel oral anticoagulants.
Dr. Goldhaber showed through a series of clinical trials that right ventricular dilatation and hypokinesis predict an adverse prognosis in acute pulmonary embolism. Furthermore, these trials showed that systemic and catheter-based ultrasound-facilitated thrombolytic therapy more rapidly than heparin restored normal right ventricular function. He also conducted a randomized trial demonstrating that electronic medical alerts for high-risk hospitalized patients not receiving venous thromboembolism prophylaxis reduce the symptomatic DVT and pulmonary embolism rates by more than 40%. For his work on prevention of venous thromboembolism, Dr. Goldhaber received the Certificate of Appreciation from the Surgeon General of the United States. In 2015, he received the Distinguished Scientist Award from the American Heart Association.
Dr. Goldhaber directs a series of Harvard Medical School courses, and he is president and founding director of the nonprofit organization North American Thrombosis Forum (www.NATFonline.org), which focuses on thrombosis education for healthcare providers, patients, and the public. At Brigham and
Women’s Hospital, he runs a busy outpatient practice of general cardiology, venous thromboembolism, and atrial fibrillation patients, and oversees the inpatient Cardiology Consult Service.